187 related articles for article (PubMed ID: 16715384)
21. Modification of electrostatic charge on inhaled carrier lactose particles by addition of fine particles.
Bennett FS; Carter PA; Rowley G; Dandiker Y
Drug Dev Ind Pharm; 1999 Jan; 25(1):99-103. PubMed ID: 10028425
[TBL] [Abstract][Full Text] [Related]
22. Spray drying lactose from organic solvent suspensions for aerosol delivery to the lungs.
Ke WR; Chang RYK; Kwok PCL; Chen D; Chan HK
Int J Pharm; 2020 Dec; 591():119984. PubMed ID: 33069893
[TBL] [Abstract][Full Text] [Related]
23. Development of inhalable dry powder formulation of basic fibroblast growth factor.
Ibrahim BM; Jun SW; Lee MY; Kang SH; Yeo Y
Int J Pharm; 2010 Jan; 385(1-2):66-72. PubMed ID: 19853028
[TBL] [Abstract][Full Text] [Related]
24. Physicochemical and in vitro deposition properties of salbutamol sulphate/ipratropium bromide and salbutamol sulphate/excipient spray dried mixtures for use in dry powder inhalers.
Corrigan DO; Corrigan OI; Healy AM
Int J Pharm; 2006 Sep; 322(1-2):22-30. PubMed ID: 16815654
[TBL] [Abstract][Full Text] [Related]
25. Investigation of the physical properties of spray-dried stabilised lysozyme particles.
Liao YH; Brown MB; Quader A; Martin GP
J Pharm Pharmacol; 2003 Sep; 55(9):1213-21. PubMed ID: 14604464
[TBL] [Abstract][Full Text] [Related]
26. Investigations of the Influences of Processing Conditions on the Properties of Spray Dried Chitosan-Tripolyphosphate Particles loaded with Theophylline.
Wei Y; Huang YH; Cheng KC; Song YL
Sci Rep; 2020 Jan; 10(1):1155. PubMed ID: 31980705
[TBL] [Abstract][Full Text] [Related]
27. Spray-Dried PulmoSphere™ Formulations for Inhalation Comprising Crystalline Drug Particles.
Weers JG; Miller DP; Tarara TE
AAPS PharmSciTech; 2019 Feb; 20(3):103. PubMed ID: 30734187
[TBL] [Abstract][Full Text] [Related]
28. Assessment of Dry Powder Inhaler Carrier Targeted Design: A Comparative Case Study of Diverse Anomeric Compositions and Physical Properties of Lactose.
Pinto JT; Zellnitz S; Guidi T; Roblegg E; Paudel A
Mol Pharm; 2018 Jul; 15(7):2827-2839. PubMed ID: 29856921
[TBL] [Abstract][Full Text] [Related]
29. Preparation and Characterization of Doripenem-Loaded Microparticles for Pulmonary Delivery.
Yildiz-Peköz A; Akbal O; Tekarslan SH; Sagirli AO; Mulazimoglu L; Morina D; Cevher E
J Aerosol Med Pulm Drug Deliv; 2018 Dec; 31(6):347-357. PubMed ID: 29877747
[No Abstract] [Full Text] [Related]
30. Development and Evaluation of Chitosan Microparticles Based Dry Powder Inhalation Formulations of Rifampicin and Rifabutin.
Pai RV; Jain RR; Bannalikar AS; Menon MD
J Aerosol Med Pulm Drug Deliv; 2016 Apr; 29(2):179-95. PubMed ID: 26406162
[TBL] [Abstract][Full Text] [Related]
31. Preparation and characterization of spray-dried powders intended for pulmonary delivery of insulin with regard to the selection of excipients.
Razavi Rohani SS; Abnous K; Tafaghodi M
Int J Pharm; 2014 Apr; 465(1-2):464-78. PubMed ID: 24560646
[TBL] [Abstract][Full Text] [Related]
32. Spray-freeze-drying production of thermally sensitive polymeric nanoparticle aggregates for inhaled drug delivery: effect of freeze-drying adjuvants.
Cheow WS; Ng ML; Kho K; Hadinoto K
Int J Pharm; 2011 Feb; 404(1-2):289-300. PubMed ID: 21093560
[TBL] [Abstract][Full Text] [Related]
33. Dry powder inhalers of gentamicin and leucine: formulation parameters, aerosol performance and in vitro toxicity on CuFi1 cells.
Aquino RP; Prota L; Auriemma G; Santoro A; Mencherini T; Colombo G; Russo P
Int J Pharm; 2012 Apr; 426(1-2):100-107. PubMed ID: 22301426
[TBL] [Abstract][Full Text] [Related]
34. Force control and powder dispersibility of spray dried particles for inhalation.
Weiler C; Egen M; Trunk M; Langguth P
J Pharm Sci; 2010 Jan; 99(1):303-16. PubMed ID: 19533606
[TBL] [Abstract][Full Text] [Related]
35. Immobilization of fine particles on lactose carrier by precision coating and its effect on the performance of dry powder formulations.
Chan LW; Lim LT; Heng PW
J Pharm Sci; 2003 May; 92(5):975-84. PubMed ID: 12712417
[TBL] [Abstract][Full Text] [Related]
36. Spray Drying of Chitosan Acid Salts: Process Development, Scaling Up and Physicochemical Material Characterization.
de la Paz N; Fernández M; López O; Garcia C; Nogueira A; Torres L; Turiño W; Heinämäki J
Mar Drugs; 2021 Jun; 19(6):. PubMed ID: 34204083
[TBL] [Abstract][Full Text] [Related]
37. Preparation and characterisation of novel spray-dried nano-structured para-aminosalicylic acid particulates for pulmonary delivery: impact of ammonium carbonate on morphology, chemical composition and solid state.
Gad S; Tajber L; Corrigan OI; Healy AM
J Pharm Pharmacol; 2012 Sep; 64(9):1264-74. PubMed ID: 22881439
[TBL] [Abstract][Full Text] [Related]
38. Agglomerated novel spray-dried lactose-leucine tailored as a carrier to enhance the aerosolization performance of salbutamol sulfate from DPI formulations.
Molina C; Kaialy W; Chen Q; Commandeur D; Nokhodchi A
Drug Deliv Transl Res; 2018 Dec; 8(6):1769-1780. PubMed ID: 29260462
[TBL] [Abstract][Full Text] [Related]
39. Development of a laser diffraction method for the determination of the particle size of aerosolised powder formulations.
Marriott C; MacRitchie HB; Zeng XM; Martin GP
Int J Pharm; 2006 Dec; 326(1-2):39-49. PubMed ID: 16942848
[TBL] [Abstract][Full Text] [Related]
40. Presence of electrostatically adsorbed polysaccharides improves spray drying of liposomes.
Karadag A; Özçelik B; Sramek M; Gibis M; Kohlus R; Weiss J
J Food Sci; 2013 Feb; 78(2):E206-21. PubMed ID: 23324113
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
